UBS Group AG 13D and 13G filings for Amneal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-30 11:04 am Purchase | 2024-09-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX | UBS Group AG | 21,491,881 6.900% | 21,491,881 (New Position) | Filing |